BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 28, 2021
View Archived Issues
Asarina reports phase IIa topline data on sepranolone in menstrual migraine
Read More
I-Mab receives Chinese clearance to conduct phase Ib study of felzartamab in SLE
Read More
China NMPA clears phase I trial of InnoCare's ICP-033 for solid tumors
Read More
Lynk cleared to begin clinical trials in China with LNK-01003 for inflammatory bowel disease
Read More
SIRPalpha-deficient macrophages orchestrate a potent antitumor immune response under radiotherapy
Read More
TPR-1 shows antibacterial activity in a panel of F. tularensis strains and a lethal infection model
Read More
Peking University Third Hospital, Chigenovo Co. describe therapies including CYP4V2 and RdCVF
Read More
Albireo synthesizes new IBAT/LBAT inhibitors
Read More
New TLR7/8/9 antagonists identified at Roche
Read More
New HIF-2alpha inhibitors identified at Arcus Biosciences
Read More
BCN Peptides patents peptides and peptide dimers derived from ADAM 12
Read More
Chemoattenuated Pf sporozoite-based vaccine shows efficacy, good tolerance and immunogenicity
Read More
First data presented for diarylquinoline TBAJ-876 as antimycobacterial compound
Read More
SAN-711 shows promising activity in rat model of orofacial pain
Read More
AstraZeneca initiates phase II/III study of COVID-19 variant vaccine AZD-2816
Read More
First-in-human data from ongoing ALPHA2 study of ALLO-501A
Read More
New resveratrol derivatives against H. pylori resistance
Read More
Neurotrophic signaling deficiency exacerbates Alzheimer's risk factors
Read More
Kymera reports interim phase I SAD data on IRAK-4 degrader KT-474
Read More
iLeukPulm study of inhaled Leukine for COVID-19 shows improved oxygenation
Read More
DSMB recommends continuation of phase Ib study of microbiome ecosystem therapy MaaT-033 in AML
Read More